Usefulness of peak systolic strain measurement by automated function imaging in the prediction of coronary perfusion in patients with acute myocardial infarction

自动功能成像技术测量峰值收缩应变在预测急性心肌梗死患者冠状动脉灌注中的应用价值

阅读:1

Abstract

BACKGROUND/AIMS: The usefulness of global longitudinal peak systolic strain (GLPSS) measurement by automated function imaging (AFI) in the prediction of perfusion status of infarct-related artery (IRA) before percutaneous coronary intervention (PCI) was evaluated. METHODS: Sixty-nine patients with acute myocardial infarction (AMI) who underwent successful primary PCI were divided into two groups; the patients with occlusion of IRA (Group I, 41 patients, 63.0 ± 14.9 years of age, 31 males) versus the patients with patent IRA (Group II, 28 patients, 63.8 ± 11.2 years of age, 15 males). GLPSS by AFI and wall-motion score index (WMSI) were analyzed in both groups. RESULTS: GLPSS was significantly decreased in Group I compared with Group II (-11.2 ± 3.7 vs. -14.1 ± 4.7%, p = 0.005), but WMSI (1.49 ± 0.28 vs. 1.35 ± 0.32, p = 0.062) did not differ between groups. GLPSS of infarct segments was significantly lower (-3.7 ± 5.4 vs. -11.4 ± 4.8%, p < 0.001), and WMSI of infarct segments was significantly higher (2.13 ± 0.57 vs. 1.66 ± 0.57, p = 0.001) in Group I compared with Group II. By receiver operation curve analysis, the area under the curve to predict IRA occlusion was 0.850 in GLPSS of infarct segments and 0.719 in WMSI of infarct segments. The optimal cut-off value to predict IRA occlusion was -9.4% in GLPSS of infarct segments (sensitivity, 85.4%; specificity, 67.9%) and 1.68 in WMSI of infarct segments (sensitivity, 78.0%; specificity, 60.7%). CONCLUSIONS: The present study suggested that GLPSS measured by AFI is a more sensitive predictor of IRA occlusion than is WMSI before PCI. Routine measurement of GLPSS by AFI can be a very useful tool in risk stratification of AMI.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。